Literature DB >> 18604650

Immune reconstitution complicated by CMV retinitis in a pediatric patient who underwent haploidentical CD34+-selected hematopoietic stem cell transplant for acute lymphoblastic leukemia.

Simone Cesaro1, Maria Paola Boaro2, Marta Pillon2, Elisabetta Calore2, Ivete Cermakova3, Katia Perruccio4, Carlo Mengoli5, Chiara Messina2.   

Abstract

We describe two episodes of CMV retinitis in a pediatric patient who underwent a CD34+ selected graft from his haploidentical father. Both recipient and donor were cytomegalovirus (CMV) seropositive. Both episodes occurred late post-grafting during a phase of complete immunological recovery with sufficient numbers of circulating CMV-specific clones. Antiviral treatment with foscarnet and ganciclovir was successful but prolonged treatment was required to prevent relapses. We hypothesize that this complication was more related to an immune reconstitution process than to an immune-deficient state post-grafting. We conclude that CMV retinitis is a late complication of HSCT that can occur despite satisfactory immune reconstitution. Usually, it is responsive to antiviral therapy. Dilated fundoscopic examination is essential both for examining patients with reduced visual acuity and for screening asymptomatic patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18604650     DOI: 10.1007/s12185-008-0126-z

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  19 in total

1.  Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation.

Authors:  Katia Perruccio; Antonella Tosti; Emanuela Burchielli; Fabiana Topini; Loredana Ruggeri; Alessandra Carotti; Marusca Capanni; Elena Urbani; Antonella Mancusi; Franco Aversa; Massimo F Martelli; Luigina Romani; Andrea Velardi
Journal:  Blood       Date:  2005-08-25       Impact factor: 22.113

2.  Characteristics of patients with cytomegalovirus retinitis in the era of highly active antiretroviral therapy.

Authors:  Douglas A Jabs; Mark L Van Natta; John H Kempen; Peter Reed Pavan; Jennifer I Lim; Robert L Murphy; Larry D Hubbard
Journal:  Am J Ophthalmol       Date:  2002-01       Impact factor: 5.258

3.  Cytomegalovirus retinitis after transplantation of positively selected CD34+ cells from HLA-mismatched donors.

Authors:  H Miyoshi; K Tanaka-Taya; Y Nagae; T Aono; H Fujisaki; Y Matsuda; Y Osugi; J Hara; Y Mori; T Sunagawa; Y Tano; S Okada; K Yamanishi
Journal:  Pediatr Infect Dis J       Date:  1998-04       Impact factor: 2.129

4.  Early viral complications following CD34-selected autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma.

Authors:  T Miyamoto; H Gondo; Y Miyoshi; H Shigematsu; T Minematsu; K Takenaka; K Tanimoto; T Horiuchi; Y Asano; S Inaba; Y Minamishima; Y Niho
Journal:  Br J Haematol       Date:  1998-02       Impact factor: 6.998

5.  Foscarnet therapy for ganciclovir-resistant cytomegalovirus retinitis after stem cell transplantation: effective monitoring of CMV infection by quantitative analysis of CMV mRNA.

Authors:  H Ohta; Y Matsuda; S Tokimasa; A Sawada; J Y Kim; J Sashihara; K Amo; H Miyagawa; K Tanaka-Taya; S Yamamoto; Y Tano; T Aono; K Yamanishi; S Okada; J Hara
Journal:  Bone Marrow Transplant       Date:  2001-06       Impact factor: 5.483

6.  Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation.

Authors:  Pierre Reusser; Hermann Einsele; John Lee; Liisa Volin; Montserrat Rovira; Dan Engelhard; Jürgen Finke; Catherine Cordonnier; Hartmut Link; Per Ljungman
Journal:  Blood       Date:  2002-02-15       Impact factor: 22.113

7.  CMV retinitis after cessation of ganciclovir therapy for CMV antigenemia in an unrelated BMT recipient.

Authors:  N Suzuki; T Kudoh; N Mizue; J Watanabe; M Ikehata; M Tateno; H Ooguro; S Chiba
Journal:  Bone Marrow Transplant       Date:  1998-11       Impact factor: 5.483

8.  CMV retinitis after allogeneic bone marrow transplantation: a report of five cases.

Authors:  Kajsa Larsson; B Lönnqvist; O Ringdén; B Hedquist; P Ljungman
Journal:  Transpl Infect Dis       Date:  2002-06       Impact factor: 2.228

Review 9.  CMV-specific T cell therapy.

Authors:  Hermann Einsele; Markus Kapp; Götz Ulrich Grigoleit
Journal:  Blood Cells Mol Dis       Date:  2007-09-11       Impact factor: 3.039

10.  Hematopoietic stem cell transplantation from alternative donors for high-risk acute leukemia: the haploidentical option.

Authors:  Franco Aversa; Antonio Tabilio; Andrea Velardi; Adelmo Terenzi; Franca Falzetti; Alessandra Carotti; Teresa Aloisi; Maria Liga; Mauro Di Ianni; Tiziana Zei; Antonella Santucci; Massimo F Martelli
Journal:  Curr Stem Cell Res Ther       Date:  2007-01       Impact factor: 3.828

View more
  2 in total

Review 1.  Imaging spectrum of central nervous system complications of hematopoietic stem cell and solid organ transplantation.

Authors:  Andrés Server; Nuria Bargalló; Yngvar Fløisand; Jon Sponheim; Francesc Graus; John K Hald
Journal:  Neuroradiology       Date:  2017-03-02       Impact factor: 2.804

2.  Neurological complications of transplantation: part I: hematopoietic cell transplantation.

Authors:  Amy A Pruitt; Francesc Graus; Myrna R Rosenfeld
Journal:  Neurohospitalist       Date:  2013-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.